Controlled-release formulations

Details for Australian Patent Application No. 2007272951 (hide)

Owner Mutual Pharmaceutical Company, Inc.

Inventors Arnold, Kristin; Nutalapati, Siva Rama K.; Piya, Ishari

Agent Cullen & Co

Pub. Number AU-A-2007272951

PCT Pub. Number WO2008/008434

Priority 60/859,772 17.11.06 US; 60/819,914 11.07.06 US

Filing date 11 July 2007

Wipo publication date 17 January 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2008/008434 Priority application(s): WO2008/008434

5 March 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 29 Jan 2009

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272954-Methods of treating obesity using satiety factors

2007272950-Substituted acylanilides and methods of use thereof